Caitlin Kontulis
Direttore Finanziario/CFO presso PHIO PHARMACEUTICALS CORP.
Patrimonio netto: 7 514 $ in data 30/04/2024
Profilo
Caitlin Kontulis is currently working as the Secretary, VP-Finance & Administration at Phio Pharmaceuticals Corp.
Previously, she worked as the Interim Chief Accounting Officer at Galena Biopharma, Inc. She completed her graduate degree from Northeastern University in 2008 and her undergraduate degree from Bryant University in 2007.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
01/03/2024 | 10 643 ( 0.23% ) | 7 514 $ | 30/04/2024 |
Posizioni attive di Caitlin Kontulis
Società | Posizione | Inizio |
---|---|---|
PHIO PHARMACEUTICALS CORP. | Direttore Finanziario/CFO | - |
Precedenti posizioni note di Caitlin Kontulis
Società | Posizione | Fine |
---|---|---|
Galena Biopharma, Inc.
Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | Comptroller/Controller/Auditor | - |
Formazione di Caitlin Kontulis
Bryant University | Undergraduate Degree |
Northeastern University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
PHIO PHARMACEUTICALS CORP. | Health Technology |
Aziende private | 1 |
---|---|
Galena Biopharma, Inc.
Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | Health Technology |
- Borsa valori
- Insiders
- Caitlin Kontulis